Protection of mice from lethal herpes simplex virus infection by vaccination with a secreted form of cloned glycoprotein D

67Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Mammalian cell lines have been constructed which synthesize a truncated form of the HSV 1 glycoprotein D (gD). The truncated protein lacks the carboxy-terminal 93 amino acids, is glycosylated, and is constitutively secreted to the culture medium. Radioimmunoprecipitation experiments demonstrate that truncation of the protein did not drastically alter its anti-genie structure. Vaccination of mice with the secreted HSV 1 gD resulted in the induction of antibodies able to neutralize both HSV 1 and HSV 2 in vitro. Mice vaccinated with this antigen were protected from a lethal challenge with either HSV 1 or HSV 2. © 1984, Nature Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Lasky, L. A., Dowbenko, D., Simonsen, C. C., & Berman, P. W. (1984). Protection of mice from lethal herpes simplex virus infection by vaccination with a secreted form of cloned glycoprotein D. Bio/Technology, 2(6), 527–532. https://doi.org/10.1038/nbt0684-527

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free